Type
. Disability index for leprosy patients. Bulletin of the World Health Organization. 1971;44(5):709-13.
Type
. Phagocytosis-promoting effect of clofazimine (B 663) in patients with subnormal granulocyte function. Scandinavian journal of haematology. 1971;8(5):400-4.
Type
. Was leprosy common in Palestine in New Testament times?. The Zambia nurse journal. 1970;4(3):10-1.
Type
. [Leprotic lesions in the oral cavity--their importance in prevention]. Estomatologia e cultura. 1970;4(2):123-8.
Type
. [Acid resistant bacillus found in the dental pulp of leprosy patients]. Revista de la Asociacion Odontologica de Costa Rica. 1970;6:3-8.
Type
Immunological problems in leprosy research. 1. Clinical and pathological spectrum of leprosy. Bulletin of the World Health Organization. 1970;43(6):879-90.
Type
. An anthropological method for measuring exposure to leprosy in a leproxy-endemic population at Karimui, New Guinea. Bulletin of the World Health Organization [Internet]. 1970;43(6):863-77. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427817/pdf/bullwho00210-0099.pdf
Type
. Studies towards the standardization of lepromin. Progress and prospects. Bulletin of the World Health Organization [Internet]. 1970;42(5):703-9. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2427501/pdf/bullwho00216-0054.pdf
Type
. Therapy of leprosy. Bulletin of the World Health Organization. 1970;42(5):667-72.
Type
. Evaluation of leprosy control programmes: some suggestions for operational and epidemiological assessments. Bulletin of the World Health Organization. 1970;42(4):631-4.